Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cardiovasc. Med.

Sec. Cardiac Rhythmology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1615707

This article is part of the Research TopicCardioimmunology and Arrhythmias: Mechanism, Diagnosis and Novel TherapyView all 6 articles

Research Advances in the Pathogenesis and Therapeutic Interventions of Helicobacter pylori and Atrial Fibrillation

Provisionally accepted
Zhaofen  WangZhaofen Wang1Haijuan  WangHaijuan Wang1Yi  YanYi Yan1Peng  ChangPeng Chang2*
  • 1Lanzhou University, Lanzhou, China
  • 2Lanzhou University Second Hospital, Lanzhou, Gansu Province, China

The final, formatted version of the article will be published soon.

Atrial fibrillation (AF) has emerged as a global health challenge in the 21st century. As the most common clinical arrhythmia, AF is characterized by high rates of recurrence, disability, and mortality, coupled with substantial healthcare expenditures. Despite significant advancements in AF management in recent years, the etiological drivers and pathogenic mechanisms remain incompletely understood in a subset of patients. Since the association between Helicobacter pylori (H. pylori) infection and non-gastrointestinal diseases was reported, H. pylori-associated non-gastrointestinal diseases have gradually attracted a lot of attention, especially in cardiovascular diseases. Nevertheless, studies on the relationship between H. pylori infection and AF are still limited, and the results are controversial. Rigorous large-scale studies are warranted to delineate the pathophysiological interplay between H. pylori colonization and AF pathogenesis, with particular emphasis on determining whether eradication therapy reduces AF-associated cardiovascular morbidity or enhances long-term patient outcomes. In view of this, the aim of this paper is to review the role of H. pylori in the occurrence and development of AF, to analyze the relationship between H. pylori-related cardiovascular diseases, non-cardiovascular diseases, and AF, and to explore the possible pathogenesis so as to provide new ideas and research directions for the treatment of AF, especially the intervention of idiopathic AF(iAF).

Keywords: Atrial Fibrillation, Helicobacter pylori, Pathogenesis, Inflammation, Helicobacter pylori radication

Received: 21 Apr 2025; Accepted: 17 Sep 2025.

Copyright: © 2025 Wang, Wang, Yan and Chang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Peng Chang, pchang@lzu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.